Congenital Heart Public Health Consortium (CHPHC)
Mission
The mission of the CHPHC is to prevent congenital heart defects and improve outcomes for affected children and adults. The Consortium achieves its mission by:
Providing leadership and a unified voice for public health priorities
Expanding opportunities for surveillance and public health research
Informing public policy priorities that benefit public health and affected persons
Purpose
With 2.4 million people currently living with CHDs in the United States, there is a widespread impact on communities and families. Collectively, CHDs are considered to be the most common type of birth defect, affecting approximately 1 in 110, or 40,000, babies each year, and are a leading cause of birth-defect related deaths worldwide. By working together and leveraging the knowledge and expertise of the many CHD stakeholders, the CHPHC is able to make progress toward improving the lives of these children, adults and families and the communities where they live through the following objectives:
Raise awareness of CHDs and their comorbidities
Demonstrate the prevalence of CHDs
Demonstrate the immediate and lifelong health impacts of CHDs
Synthesize the public health approach for CHDs
Appraise the health care access and cost challenges related to CHDs
About
In 2009, various organizations across federal, state and local communities came together and agreed that they could positively impact the health of those affected by congenital heart defects (CHDs) by utilizing a public health approach to address many of the issues they face. To this end, organizational members representing the voices of providers, patents, families, clinicians and researchers joined to form the Congenital Heart Public Health Consortium (CHPHC).
“The mission of the CHPHC is to prevent congenital heart defects and improve outcomes for affected children and adults.”